Hindustan Unilever Ltd Corporate Actions

HUL Cuts Prices of Key FMCG Products, But Skincare Gets Costlier

 Copy Link

In addition to softer raw material costs, intensified competition in the FMCG space has played a role in prompting this pricing adjustment.

HUL Q1 Updates: PAT jumps 8% y-o-y to ₹2,732 Crore

 Copy Link

On the other hand, EBITDA for the quarter stood at ₹3,718 Crore. This was marginally down against ₹3,744 Crore in the previous corresponding period.

Top Stocks for Today - 11th July 2025

 Copy Link

Here are some of the stocks that may see significant price movement today: Tata Consultancy Services, IREDA, Glenmark Pharma, etc.

HUL Q4 Net Profit Rises to ₹2,493 Crore

 Copy Link

HUL registered EBITDA of ₹3,466 crore in the March quarter, a 1% year-on-year increase. EBITDA margin for the quarter was 22.8%.

Top Stocks for Today - 22nd April 2025

 Copy Link

Here are some of the stocks that may see significant price movement today: Brigade Enterprises, Coal India, Hindustan Unilever, etc.

HUL names Rajneet Kohli as executive director of foods business

 Copy Link

As per the company, Kohli will take up the position on April 7, 2025, succeeding Shiva Krishnamurthy. He is leaving to pursue other opportunities.

Top Stocks for Today - 23rd January 2025

 Copy Link

Here are some of the stocks that may see significant price movement today: Hindustan Unilever, BPCL, Persistent Systems, etc.

HUL Bypasses Distributors, Targets Kiranas Directly

 Copy Link

Nearly 80% of FMCG sales in India are controlled by kirana stores, which are supplied by distributors or wholesalers.

Top Stocks for Today - 3rd December 2024

 Copy Link

Here are some of the stocks that may see significant price movement today: Torrent Pharma, Hindustan Unilever, Nazara Tech, etc.

HUL Pays ₹192.55 Crore in Tax Demand Dispute

 Copy Link

The dispute stems from an issue surrounding tax deduction at source (TDS) for a ₹3,045-crore payment HUL made to acquire intellectual property rights related to its India HFD business from GlaxoSmithKline (GSK).